Navigation Links
PAREXEL Reports First Quarter Fiscal Year 2010 Financial Results
Date:10/27/2009

usiness and are hereby acknowledged.

    CONTACTS:
        James Winschel, Senior Vice President and Chief Financial Officer
        Jill Baker, Vice President of Investor Relations
        +1-781-434-4118

                  PAREXEL International Corporation
            Consolidated Condensed Statement of Operations
                              Unaudited


                                          -----------  -----------
                                             Three       Three
                                             Months      Months
                                             Ended       Ended
                                             Sept.       Sept.
    (in thousands, except per share data)   30, 2009    30, 2008
                                           ---------   ---------

    Service revenue                         $259,763    $263,046
    Reimbursement revenue                     47,775      56,506
                                              ------      ------
      Total revenue                          307,538     319,552

    Costs and expenses:
        Direct costs                         166,829     171,364
        Reimbursable out-of-pocket
         expenses                             47,775      56,506
        Selling, general and
         administrative                       60,353      57,725
        Depreciation                          11,569       9,929
        Amortization                           2,536       2,035
      Total costs and expenses               289,062     297,559

    Income from operations                    18,476      21,993

    Other expense                               (780)       (678)
                                                ----        ----

    Income before income taxes                17,696      21,315

    Provision for income taxes                 5,255       7,696
    Effective tax rate                          29.7%       36.1%


    Net income                
'/>"/>
SOURCE PAREXEL International Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. PAREXEL International to Present at William Blair Emerging Growth Stock Conference
2. PAREXEL Reaches Milestone in Management of Oncology Trials Over Last Five Years Involving 175,000 Patients Worldwide
3. PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru
4. PAREXEL Data Reveal A Record High Number of Clinical Trials Initiated
5. PAREXEL Expands Global Clinical Pharmacology Capabilities
6. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
7. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Second Quarter and First Six Months of Fiscal Year 2010
8. NxStage(R) Reports Significant Interim FREEDOM Study Results
9. Hospira Reports Third-Quarter 2009 Results
10. Peregrine Pharmaceuticals Reports 61% Objective Response Rate in 46-Patient Bavituximab Phase II Trial in Advanced Breast Cancer
11. Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... 05, 2015 Research and Markets ( ... "India Pharma Outlook 2015: Accelerating growth to the next ... report to their offering. Domestic ... the 2013 caused by the market,s reaction to the ... to continue to be healthy, as the momentum continues ...
(Date:3/5/2015)... and HAMPTON, N.J. , March ... MNK ), a leading global specialty biopharmaceutical ... announced today that they have entered into a definitive ... Ikaria, Inc. from a Madison Dearborn -led investor ... Subject to customary closing conditions, the ...
(Date:3/5/2015)... 5, 2015 According to a ... Product (Systems and Disposables), by Type (Invasive, Minimally Invasive, ... and Ambulatory Sites) - Analysis & Global Forecast to ... expected to reach $1,107.4 Million by 2019 from $887.8 ... a CAGR of 4.5% during the forecast period. ...
Breaking Medicine Technology:India Pharma Outlook 2015: Accelerating growth to the next level - Moving up the value chain beyond Generics 2India Pharma Outlook 2015: Accelerating growth to the next level - Moving up the value chain beyond Generics 3Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 2Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 3Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 4Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 5Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 6Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 7Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 8Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 9Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 2Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 3Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 4
... Texas, April 8, 2011 The MED Group, a ... leading group purchasing and business solutions company focused on ... creation of The MED Group National Orthotics and Prosthetics ... The MED Group and will be leading the development ...
... 8, 2011 Amgen (NASDAQ: AMGN ), ... of its operations in Brazil, including the acquisition of ... agreed to reacquire rights in Brazil to its products ... Hypermarcas). Together, these transactions will provide Amgen a significant ...
Cached Medicine Technology:The MED Group Launches the New National Orthotics & Prosthetics Network 2Amgen Establishes Commercial Operations in Brazil 2Amgen Establishes Commercial Operations in Brazil 3Amgen Establishes Commercial Operations in Brazil 4
(Date:3/5/2015)... 05, 2015 Central Nebraska Imaging (CNI) ... including the brand’s new logo and optimized website. ... practice’s modern approach to expert diagnostic imaging, centered on ... be built to be a resource for Nebraska patients ... automated forms, communication and referral functionality, video content and ...
(Date:3/5/2015)... 05, 2015 HomeCEUConnection.com is ... with extra savings on their nutrition CEUs. ... health and nutrition, HomeCEUConnection.com is offering 10% ... promo code, NUTRITION2015 . , High ... , HomeCEUConnection.com provides high-quality continuing education courses ...
(Date:3/5/2015)... Angeles, CA (PRWEB) March 05, 2015 ... article titled “Butt Augmentation, Labiaplasty on the Rise, Plastic ... reported by the American Society for Aesthetic Plastic ... Surgeons . Both groups reported a year-over-year doubling of ... of the physicians quoted in the article, this increase ...
(Date:3/5/2015)... In honor of National Drug Facts Week, ... and alcohol abuse in schools and communities across America, ... information on some of the dangers and statistics involved ... Institute on Drug Abuse, this annual promotion of the ... illusions that teens and young adults get from television, ...
(Date:3/5/2015)... At the 7th Annual Mississippi Addiction ... treatment met today in Jackson, Mississippi to listen to ... the numerous respected speakers will be William S. ... that pain medications have had in today’s opiate overdose ... "It is hard to believe that much of the ...
Breaking Medicine News(10 mins):Health News:Central Nebraska Imaging Center Gets Rebranding 2Health News:HomeCEUConnection.com Offers Nutrition CEUs this March to Celebrate Nutrition Month 2Health News:The Kim Kardashian and Jennifer Lopez Effect: Butt Augmentations Double from 2013 to 2014 2Health News:A Forever Recovery Issues New Tips for Sobriety for National Drug Facts Week 2Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 2Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 3
... neither improved nor deteriorated. There are 89 new cases, 2 deaths ... the number of dengue cases at the All India Institute of ... viral fever cases is also decreasing; however, the doctors cautioned that ... cases have come down but the outbreak isn't over," said Medical ...
... hopes of a team of eminent plastic surgeons led by ... waiting for the// final approval from The Royal Free hospital’s ... transplant which would involve the complete replacement of a disfigured ... ,Although the hospital had granted permission to ...
... in clinical use for decades, a small, sweet-tasting compound ... cure for epilepsy.// ,2-deoxy-glucose, or 2DG, has ... cancer imaging studies in humans. But now, researchers at ... blocks the onset of epileptic seizures in laboratory rats. ...
... must get its act together to check the perilous trend of ... suggested a cap on the// embryo, allowing only one embryo at ... the Human Fertilization and Embryology Authority (HFEA) has suggested that the ... two to one for patients who are not on the wrong ...
... Taxotere(docetaxel) from Sanofi-Aventis has been approved for its treatment ... showed that patients given chemotherapy with// Taxotere survived an ... to 8.3 months with standard drugs. ,The ... cisplatin and fluorouracil chemotherapy in locally advanced squamous cell ...
... gene therapy for Parkinson's disease has given the green signal ... symptoms for patients,// according to the reports of two groups ... and last week the researchers reported that each of the ... received some benefit and none had significant side effects. ...
Cached Medicine News:Health News:Commonplace Sugar Compound Silences Seizures 2Health News:Commonplace Sugar Compound Silences Seizures 3Health News:Gene therapy Beneficial in Parkinson's Disease 2Health News:Gene therapy Beneficial in Parkinson's Disease 3
... a vital dye, used in matured cataract ... fibrous tissue enables the surgeon to see ... preparation of trypan blue combined with sodium ... tolerated following intraocular injection into the anterior ...
Exclusive oxidized regenerated cellulose technology. The only oxidized regenerated cellulose hemostat line, surgicel absorbable hemostat delivers a unique combination of effectiveness, absorbability,...
Refkeratometer...
Portable, easy to align, automatic measurement, automatic fogging. Accurate and dependable readings. Infrared printer communication. Rechargeable battery. Integrates with the TRS-2100 and EPIC-2100 r...
Medicine Products: